In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain.
The development of an in vivo procedure for the induction of massive proliferation, directed migration, and neurodifferentiation (PMD) in the damaged adult central nervous system would hold promise for the treatment of human neurodegenerative disorders such as Parkinson's disease. We investigated the in vivo induction of PMD in the forebrain of the adult rat by using a combination of 6-hydroxydopamine lesion of the substantia nigra dopaminergic neurons and infusions of transforming growth factor alpha (TGFalpha) into forebrain structures. Only in animals with both lesion and infusion of TGFalpha was there a rapid proliferation of forebrain stem cells followed by a timed migration of a ridge of neuronal and glial progenitors directed toward the region of the TGFalpha infusion site. Subsequently, increasing numbers of differentiated neurons were observed in the striatum. In behavioral experiments, there was a significant reduction of apomorphine-induced rotations in animals receiving the TGFalpha infusions. These results show that the brain contains stem cells capable of PMD in response to an exogenously administered growth factor. This finding has significant implications with respect to the development of treatments for both acute neural trauma and neurodegenerative diseases.
Fallon
J
J
Departments of Anatomy and Neurobiology, Medicine, and Pharmacology, University of California, Irvine, CA 92697-1275, USA. jfallon@uci.edu
Reid
S
S
Kinyamu
R
R
Opole
I
I
Opole
R
R
Baratta
J
J
Korc
M
M
Endo
T L
TL
Duong
A
A
Nguyen
G
G
Karkehabadhi
M
M
Twardzik
D
D
Patel
S
S
Loughlin
S
S
D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division; D002465:Cell Movement / Q000502:physiology*; D008297:Male; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D016627:Oxidopamine / Q000008:administration & dosage; D016548:Prosencephalon / Q000166:cytology* / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D016211:Transforming Growth Factor alpha / Q000008:administration & dosage / Q000235:genetics
D016211:Transforming Growth Factor alpha; D016627:Oxidopamine